Almost 10% of Canadians are struggling with the effects of neurological disorders. In the coming decades, as our population continues to grow, this number is expected to grow.
From Alzheimer’s to spinal cord injuries, these conditions span all ages, impacting daily life and mental health. With your help, we can decode the secrets of neuroscience to unlock new discoveries and treatments for patients suffering from neurological disorders.
There are no cures or treatments available to slow or stop neurodegenerative disorders such as dementia and Alzheimer’s. Further to this, persistent injuries such as concussions, sustained while playing sports, can increase the risk of long-term neurodegeneration. Today, there are approximately 750,000 Canadians living with dementia.
Therefore, in a bid to increase our understanding of neurodegenerative diseases and perhaps, one day, help inform treatment, the Dale E. Creighton Brain & Biobank (DECBB) has begun collecting brain tissue samples from people affected by neurodegeneration. To this end, London Health Sciences Centre (LHSC) scientist and lead investigator at DECBB, Dr. Elizabeth Finger, has identified an exciting investment opportunity to support project sustainability, thereby allowing vital research in the field to continue. Learn more.
The Brain Tumour Tissue Biobank (BTTB) at London Health Sciences Centre is a vital resource and has contributed to advancing brain tumour research in 12 countries around the world. Here’s how your support makes a difference:
Epilepsy Research
Advancing epilepsy research through cutting-edge neuromodulation, intercranial electrode studies and a national Epilepsy Data Registry, the team aims to revolutionize treatment options and improve patient outcomes, especially for women. This work focuses on deep brain stimulation, data-driven analysis and addressing the unique needs of female epilepsy patients across North America.
Deep Brain Stimulation (DBS) surgery is a groundbreaking procedure that involves placing electrodes in the brain to alter brain activity and alleviate symptoms of various neurological conditions. Performing the first robot-assisted DBS surgery in Canada, Dr. Jonathan Lau ushered in a new technique, which boasts unparalleled precision.
This technology reduces electrode placement time from hours to just 45 minutes and has achieved a remarkable 90 per cent reduction in seizure occurrences. DBS provides significant therapeutic benefits for treatment-resistant conditions like Parkinson's disease, essential tremor, dystonia, chronic pain, obsessive-compulsive disorders and major depression, revolutionizing the field of neurosurgery and improving patients' quality of life. Learn more.
Stroke fellowships at London Health Sciences Centre (LHSC) are essential for advancing stroke care and training the next generation of specialists. These prestigious programs, made possible by generous donor support, attract the world's top medical minds to LHSC.
Donor-funded fellowships enable promising researchers to innovate and refine patient care strategies, ensuring personalized treatment and better outcomes. Your support empowers these experts to make lasting impacts on stroke care, benefiting patients locally and globally.
Donors play a crucial part in the discovery of new and effective ways to care for patients by helping fund important research initiatives, technological advancements and personalized medicine. Anything's possible when you choose to care.
